8 results on '"Dubin, G"'
Search Results
2. Cryo-EM structure of Trypanosoma cruzi (MDH)4-PEX5 complex
- Author
-
Lipinski, O., primary, Sonani, R.R., additional, Blat, A., additional, Jemiola-Rzeminska, M., additional, Patel, S.N., additional, Sood, T., additional, and Dubin, G., additional
- Published
- 2024
- Full Text
- View/download PDF
3. Crystal structure of O'nyong'nyong virus capsid protease (106-256)
- Author
-
Plewka, J., primary, Chykunova, Y., additional, Wilk, P., additional, Sienczyk, M., additional, Dubin, G., additional, and Pyrc, K., additional
- Published
- 2024
- Full Text
- View/download PDF
4. Structural dynamics of the TPR domain of the peroxisomal cargo receptor Pex5 in Trypanosoma.
- Author
-
Banasik M, Napolitano V, Blat A, Abdulkarim K, Plewka J, Czaplewski C, Gieldon A, Kozak M, Wladyka B, Popowicz G, and Dubin G
- Abstract
Peroxisomal protein import has been identified as a valid target in trypanosomiases, an important health threat in Central and South America. The importomer is built of multiple peroxins (Pex) and structural characterization of these proteins facilitates rational inhibitor development. We report crystal structures of the Trypanosoma brucei and T. cruzi tetratricopeptide repeat domain (TPR) of the cytoplasmic peroxisomal targeting signal 1 (PTS1) receptor Pex5. The structure of the TPR domain of TbPex5 represents an apo-form of the receptor which, together with the previously determined structure of the complex of TbPex5 TPR and PTS1 demonstrate significant receptor dynamics associated with signal peptide recognition. The structure of the complex of TPR domain of TcPex5 with PTS1 provided in this study details the molecular interactions that guide signal peptide recognition at the atomic level in the pathogenic species currently perceived as the most relevant among Trypanosoma. Small - angle X - ray scattering (SAXS) data obtained in solution supports the crystallographic findings on the compaction of the TPR domains of TbPex5 and TcPex5 upon interaction with the cargo., Competing Interests: Declaration of competing interest None. The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper., (Copyright © 2024. Published by Elsevier B.V.)
- Published
- 2024
- Full Text
- View/download PDF
5. Crystal structure of glycerol kinase from Trypanosoma cruzi, a potential molecular target in Chagas disease.
- Author
-
Lipiński O, Sonani RR, and Dubin G
- Subjects
- Crystallography, X-Ray, Protozoan Proteins chemistry, Protozoan Proteins metabolism, Models, Molecular, Humans, Binding Sites, Glycerol chemistry, Protein Conformation, Trypanosoma cruzi enzymology, Glycerol Kinase chemistry, Glycerol Kinase metabolism, Chagas Disease drug therapy, Chagas Disease parasitology
- Abstract
Chagas disease is a neglected tropical disease caused by the protozoan parasite Trypanosoma cruzi. It bears a significant global health burden with limited treatment options, thus calling for the development of new and effective drugs. Certain trypanosomal metabolic enzymes have been suggested to be druggable and valid for subsequent inhibition. In this study, the crystal structure of glycerol kinase from T. cruzi, a key enzyme in glycerol metabolism in this parasite, is presented. Structural analysis allowed a detailed description of the glycerol binding pocket, while comparative assessment pinpointed a potential regulatory site which may serve as a target for selective inhibition. These findings advance the understanding of glycerol metabolism in eukaryotes and provide a solid basis for the future treatment of Chagas disease.
- Published
- 2024
- Full Text
- View/download PDF
6. Despite the odds: formation of the SARS-CoV-2 methylation complex.
- Author
-
Matsuda A, Plewka J, Rawski M, Mourão A, Zajko W, Siebenmorgen T, Kresik L, Lis K, Jones AN, Pachota M, Karim A, Hartman K, Nirwal S, Sonani R, Chykunova Y, Minia I, Mak P, Landthaler M, Nowotny M, Dubin G, Sattler M, Suder P, Popowicz GM, Pyrć K, and Czarna A
- Subjects
- Methylation, Exoribonucleases metabolism, Exoribonucleases genetics, Humans, Protein Binding, RNA Caps metabolism, RNA Caps genetics, Allosteric Regulation, COVID-19 virology, COVID-19 genetics, Protein Multimerization, Virus Replication genetics, RNA, Messenger metabolism, RNA, Messenger genetics, RNA, Messenger chemistry, Viral Regulatory and Accessory Proteins, SARS-CoV-2 genetics, SARS-CoV-2 metabolism, Viral Nonstructural Proteins metabolism, Viral Nonstructural Proteins genetics, Viral Nonstructural Proteins chemistry, Methyltransferases metabolism, Methyltransferases genetics, Methyltransferases chemistry, RNA, Viral metabolism, RNA, Viral chemistry, RNA, Viral genetics
- Abstract
Coronaviruses modify their single-stranded RNA genome with a methylated cap during replication to mimic the eukaryotic mRNAs. The capping process is initiated by several nonstructural proteins (nsp) encoded in the viral genome. The methylation is performed by two methyltransferases, nsp14 and nsp16, while nsp10 acts as a co-factor to both. Additionally, nsp14 carries an exonuclease domain which operates in the proofreading system during RNA replication of the viral genome. Both nsp14 and nsp16 were reported to independently bind nsp10, but the available structural information suggests that the concomitant interaction between these three proteins would be impossible due to steric clashes. Here, we show that nsp14, nsp10, and nsp16 can form a heterotrimer complex upon significant allosteric change. This interaction is expected to encourage the formation of mature capped viral mRNA, modulating nsp14's exonuclease activity, and protecting the viral RNA. Our findings show that nsp14 is amenable to allosteric regulation and may serve as a novel target for therapeutic approaches., (© The Author(s) 2024. Published by Oxford University Press on behalf of Nucleic Acids Research.)
- Published
- 2024
- Full Text
- View/download PDF
7. Peptide-based inhibitors targeting the PD-1/PD-L1 axis: potential immunotherapeutics for cancer.
- Author
-
Bojko M, Węgrzyn K, Sikorska E, Ciura P, Battin C, Steinberger P, Magiera-Mularz K, Dubin G, Kulesza A, Sieradzan AK, Spodzieja M, and Rodziewicz-Motowidło S
- Abstract
The PD-1/PD-L1 complex belongs to the group of inhibitory immune checkpoints and plays a critical role in immune regulation. The PD-1/PD-L1 axis is also responsible for immune evasion of cancer cells, and this complex is one of the main targets of immunotherapies used in oncology. Treatment using immune checkpoint inhibitors is mainly based on antibodies. This approach has great therapeutic potential; however, it also has major drawbacks and can induce immune-related adverse events. Thus, there is a strong need for alternative, non-antibody-based therapies using small molecules, peptides, or peptidomimetics. In the present study, we designed, synthesized, and evaluated a set of PD-1-targeting peptides based on the sequence and structure of PD-L1. The binding of these peptides to PD-1 was investigated using SPR and ELISA. We also assessed their ability to compete with PD-L1 for binding to PD-1 and their inhibitory properties against the PD-1/PD-L1 complex at the cellular level. The best results were obtained for the peptide PD-L1(111-127)
(Y112C-I126C) , named (L11), which displaced PD-L1 from binding to PD-1 in the competitive assay and inhibited the formation of the PD-1/PD-L1 complex. The (L11) peptide also exhibited strong affinity for PD-1. NMR studies revealed that (L11) does not form a well-defined secondary structure; however, MD simulation indicated that (L11) binds to PD-1 at the same place as PD-L1. After further optimization of the structure, the peptide inhibitor obtained in this study could also be used as a potential therapeutic compound targeting the PD-1/PD-L1 axis., Competing Interests: Declaration of competing interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper., (Copyright © 2024. Published by Elsevier Inc.)- Published
- 2024
- Full Text
- View/download PDF
8. Autoinhibition of suicidal capsid protease from O'nyong'nyong virus.
- Author
-
Chykunova Y, Plewka J, Wilk P, Torzyk K, Sienczyk M, Dubin G, and Pyrc K
- Subjects
- Humans, Capsid chemistry, Capsid metabolism, O'nyong-nyong Virus metabolism, Peptide Hydrolases metabolism, Suicidal Ideation, Tryptophan metabolism, Endopeptidases metabolism, Capsid Proteins chemistry, Alphavirus metabolism
- Abstract
Alphaviruses pose a significant threat to public health. Capsid protein encoded in the alphaviral genomes constitutes an interesting therapy target, as it also serves as a protease (CP). Remarkably, it undergoes autoproteolysis, leading to the generation of the C-terminal tryptophan that localizes to the active pocket, deactivating the enzyme. Lack of activity hampers the viral replication cycle, as the virus is not capable of producing the infectious progeny. We investigated the structure and function of the CP encoded in the genome of O'nyong'nyong virus (ONNV), which has instigated outbreaks in Africa. Our research provides a high-resolution crystal structure of the ONNV CP in its active state and evaluates the enzyme's activity. Furthermore, we demonstrated a dose-dependent reduction in ONNV CP proteolytic activity when exposed to indole, suggesting that tryptophan analogs may be a promising basis for developing small molecule inhibitors. It's noteworthy that the capsid protease plays an essential role in virus assembly, binding viral glycoproteins through its glycoprotein-binding hydrophobic pocket. We showed that non-aromatic cyclic compounds like dioxane disrupt this vital interaction. Our findings provide deeper insights into ONNV's biology, and we believe they will prove instrumental in guiding the development of antiviral strategies against arthritogenic alphaviruses., Competing Interests: Declaration of competing interest Krzysztof Pyrc, Adam Lesner, and Marcin Sienczyk reports financial support was provided by National Science Centre Poland., (Copyright © 2024. Published by Elsevier B.V.)
- Published
- 2024
- Full Text
- View/download PDF
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.